Adtalem Global Education Reports Strong Q3 Growth

Adtalem Global Education ( (ATGE) ) has released its Q3 earnings. Here is a breakdown of the information Adtalem Global Education presented to its investors.

Adtalem Global Education is a leading provider of healthcare education in the United States, offering high-quality academic programs to prepare a practice-ready workforce. The company is known for its expansive network of institutions and commitment to excellence and access.

In its third quarter of fiscal year 2025, Adtalem Global Education reported significant growth, with total enrollment increasing by 9.8% year-over-year and revenue rising by 12.9% to $466.1 million. The company’s diluted earnings per share reached $1.59, with an adjusted EPS of $1.92, marking a 28% growth compared to the previous year.

Key financial highlights include a robust net income of $60.8 million and an adjusted EBITDA of $127.8 million, reflecting a 19.3% increase year-over-year. The company completed a $300 million share repurchase program and announced a new $150 million program. Chamberlain University and Walden University both achieved notable enrollment growth, contributing to the overall positive performance.

Adtalem’s strategic focus on delivering flexible and career-relevant programs has driven consistent enrollment growth across its institutions. The company’s “Growth with Purpose” strategy continues to generate sustainable returns, with significant investments in innovative programs to meet the rising demand for healthcare professionals.

Looking ahead, Adtalem has raised its fiscal year 2025 guidance, projecting revenue between $1,760 million and $1,775 million and adjusted earnings per share in the range of $6.40 to $6.60. The company remains committed to transforming higher education and meeting the needs of communities across the U.S.